JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

National Institutes of Health Chiari Research Conference: state of the research and new directions.

OBJECTIVE: To establish the current Chiari knowledge base and develop recommendations for future research.

METHODS: Chiari malformation: state of the research and new directions was a two-day, National Institutes of Health sponsored conference. The agenda included review presentations and working groups tasked with developing specific, achievable research recommendations. Content for both the review presentations and working groups was divided into six areas: pathophysiology, symptoms and diagnosis, engineering and imaging analysis, treatment, pediatric issues, and related conditions.

RESULTS: The articles in this issue represent the knowledge base that was developed at the conference, plus subsequent literature reviews. There are significant gaps in the understanding of Chiari malformation, including a clinically relevant definition of Chiari, confusing terminology, subjective diagnostic criteria, and a well-accepted standard of care. These knowledge gaps are not surprising given the relative lack of Chiari research compared to similar neurological conditions and the preponderance of case reports in the published Chiari literature. The lack of understanding, and research, regarding Chiari translates directly into negative patient experiences and outcomes.

CONCLUSIONS: Implementation of the recommendations developed at the conference would not only further expand the current understanding of the condition, but would likely have a significant, positive impact on patient experiences and outcomes.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app